Abstract
Small trials have been largely overlooked in the early part of the COVID-19 pandemic in favour of “mega-trials”. As new therapies are urgently needed, phase 2 “proof of concept” studies are crucial as we move into a new phase of pandemic research.
Original language | English |
---|---|
Article number | 2004116 |
Number of pages | 4 |
Journal | European Respiratory Journal |
Volume | 56 |
Issue number | 6 |
Early online date | 24 Dec 2020 |
DOIs | |
Publication status | Published - Dec 2020 |
Keywords
- COVID-19
- Evidence-Based Medicine
- Humans
- Methylprednisolone
- Pandemics
- SARS-CoV-2
- Steroids